Breaking News
Sort by:
Top Post
Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience
Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]
Pheon Therapeutics Launches with $68 Million in Financing to Advance Novel Antibody-Drug Conjugates for Treatment of Solid Tumors
Pheon Therapeutics (Pheon), a leading Antibody-Drug Conjugate (ADC) specialist developing next generation ADCs for a wide […]
CraniUS Closes ~$20 Million Series A Funding Round
CraniUS LLC, an R&D company focused on building groundbreaking treatments for patients with chronic brain […]
Health and Social Care Secretary Sets Out Plan for Patients With New Funding to Bolster Social Care Over Winter
‘Our plan for patients’ will inject £500 million of additional funding into adult social care […]
Surge Raises $2.6M, Secures Exclusive Licensing Agreement with Stanford to Make Surgeries Safer
Biotech and medical AI innovator Surge announced a $2.6 million round co-led by HCVC, a global early-stage fund dedicated […]
Pattern Health Closes $3.3M Series A to Expand Digital Health Research and Clinical Implementation Capabilities
Pattern Health, a digital health company, today announced the closing of a $3.3 million series A funding […]
Rivus Pharmaceuticals Closes $132 Million Series B Financing to Advance HU6 for the Treatment of Obesity and Cardio-Metabolic Disorders
Rivus Pharmaceuticals Inc., a clinical-stage biopharmaceutical company dedicated to improving cardio-metabolic health, today announced the […]
Novo Nordisk Foundation Launches Major Investment to Develop the First Quantum Computer Dedicated to Life Sciences Research and the Green Transition
The Novo Nordisk Foundation has awarded a grant of US$ 200 million (DKK 1.5 billion) to establish […]
Covalab, Cimcure and Partners Receive €1.06M EUREKA Eurostars Grant to Develop New Combination Therapy for Glioblastoma
Covalab, a biotechnology company that specializes in the development and production of recombinant proteins and […]
Concord Health Partners Completes Final Close of Concord Innovation Fund II with Commitments of $150 Million
Concord Health Partners (“Concord” or the “Firm”), a healthcare focused investment firm, today announced the […]
Tridek-one Closes a €16 Million Financing Round to Develop First-in-class Immune Checkpoint Agonists
Tridek-One SAS (the ‘Company’), a leading biotech start-up specialized in the research and development of […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more